Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 22701553 | HLA (HLA) | acute kidney injury | NA | NA | NA | unclassified | |
| a multicentre study of acute kidney injury in severe sepsis and septic shock: association with inflammatory phenotype and hla genotype. | |||||||
| 22701553 | HLA (HLA) | severe sepsis | NA | NA | NA | only_studied | |
| to investigate the association between severity of acute kidney injury (aki) and outcome, systemic inflammatory phenotype and hla genotype in severe sepsis. | |||||||
| 22701553 | HLA (HLA) | acute kidney injury | NA | NA | NA | only_studied | |
| to investigate the association between severity of acute kidney injury (aki) and outcome, systemic inflammatory phenotype and hla genotype in severe sepsis. | |||||||
| 23891702 | HLA-DR (HLA-DR) | septic shock | NA | NA | NA | unclassified | |
| effects of corticotropin-releasing hormone on proopiomelanocortin derivatives and monocytic hla-dr expression in patients with septic shock. | |||||||
| 23891702 | HLA-DR (HLA-DR) | septic shock | NA | NA | NA | negative | |
| from the correlation between plasma concentration of a-msh and mhla-dr expression, we conclude that in patients with septic shock the down-regulation of mhal-dr expression is accompanied by the loss of monocytic release of a-msh into the cardiovascular compartment. | |||||||
| 28072859 | HLA-DR (HLA-DR) | septic shock | NA | NA | NA | positive | |
| a decrease of tcr diversity and monocyte hla-dr expression were observed in the early stage of septic shock, while cd4+ t cells displayed an increase of pd-1 expression. | |||||||
| 32188504 | HLA-DR (HLA-DR) | septic shock | NA | NA | NA | unclassified | |
| we used a high-density microarray and rt-qpcr to evaluate the herv and mammalian apparent long terminal repeat retrotransposons (malr) transcriptome in a pilot study that included 20 selected septic shock patients, stratified on mhla-dr expression, with samples collected on day 1 and day 3 after inclusion. | |||||||
| 32188504 | HLA-DR (HLA-DR) | septic shock | NA | NA | NA | unclassified | |
| we provided evidence that a subset of herv/malr and conventional genes were differentially expressed in septic shock patients, according to their immune status, using monocyte hla-dr (mhla-dr) expression as a proxy. | |||||||
| 32691839 | HLA-DR (HLA-DR) | septic shock | NA | NA | NA | only_studied | |
| then the tool was clinically assessed using samples from 10 healthy volunteers and 20 septic shock patients stratified using human leukocyte antigen-dr expression on monocytes (mhla-dr). | |||||||
| 32691839 | HLA-DR (HLA-DR) | septic shock | NA | NA | NA | unclassified | |
| the clinical assessment of the ipp markers demonstrated various gene modulations that could distinctly differentiate 3 profiles: healthy volunteers, intermediate mhla-dr septic shock patients, and low mhla-dr septic shock patients. | |||||||
Copyright 2024